Edition: India  
 
> >

Seqirus and Zambon Enter into a Partnership for Parkinson’s Disease Product in Australia and New Zealand

Business Wire Tuesday, 10 January 2017
Seqirus and Zambon Enter into a Partnership for Parkinson’s Disease Product in Australia and New ZealandMILAN--(BUSINESS WIRE)--Newron is pleased to note the news that its partner Zambon S.p.A. has entered into a partnership with Seqirus covering Zambon’s Parkinson’s disease product (Xadago®) in Australia and New Zealand.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Recent related news

New Zealand display sheer grit to thrash Australia in WT20

Dharamsala, Mar 19 (ANI): New Zealand held their nerve to edge out Australia by eight runs in a tense World Twenty20 Group Two match in Dharamsala town and moved...
ANI News - Sports

Roy smashes Kiwis as England march into W-T20 final

New Delhi, Mar 31 (ANI): Opening batsman Jason Roy struck a career-best 78 as former champions England stormed into the World Twenty20 final with a seven-wicket...
ANI News - Sports


Other recent news in Press Releases

Joint Statement from Unilever PLC and Unilever N.V. ("Unilever") and The KRAFT HEINZ Company ("KRAFT HEINZ")Veolia wins €156 million contract and contributes to drinking water access in SRI LANKA
Robert Quinlan’s New Book “Code 7 MBPD” is About the Author’s Experience with Working in the Manhattan Beach Police Department from 1968 to 1995 in SOUTHERN CALIFORNIA.R3 Stem Cell Now Offering Regenerative Medicine Treatment in LAS VEGAS and Henderson Nevada
Healthwise and Orbita will Showcase AMAZON ECHO-powered Healthcare Knowledge Assistant at HIMSS 2017, Orlando, February 19-23, Booth #1523Integrated Pain Consultants in ARIZONA Now Offering Neck Pain Relief with Radiofrequency Ablation
Nexif Energy Announces Milestones on New Power Generation Projects in AUSTRALIA

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter